IP Library Granted Patent US 9,399,612
Granted Patent B2
US 9,399,612 · App. 14/605,937 · Granted Jul 26, 2016

Treatment of pervasive developmental disorders with redox-active therapeutics

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,399,612
App. No.
14/605,937
Granted
Jul 26, 2016
Kind
B2
Abstract

Methods of treating or suppressing pervasive developmental disorders (PDDs) including; autistic disorder, Asperger's syndrome, childhood disintegrative disorder (CDD), Rett's disorder, and PDD-not otherwise specified (PDD-NOS) or attention deficit/hyperactivity disorder (ADHD) comprising administering to a subject in need thereof a therapeutically effective amount of one or more compounds as disclosed herein.

Claims (14)

1. A compound selected from the group consisting of:

and solvates and hydrates thereof.

2. The compound of claim 1 selected from the group consisting of:

and solvates and hydrates thereof.

3. The compound of claim 1 of the formula:

4. The compound of claim 1 selected from the group consisting of:

and solvates and hydrates thereof.

5. The compound of claim 1 of the formula:

6. A composition comprising a compound of claim 1 and a pharmaceutically acceptable carrier.

7. A composition comprising the compound of claim 2 and a pharmaceutically acceptable carrier.

8. A composition comprising the compound of claim 3 and a pharmaceutically acceptable carrier.

9. A composition comprising the compound of claim 4 and a pharmaceutically acceptable carrier.

10. A composition comprising a compound of claim 5 and a pharmaceutically acceptable carrier.

11. A food, medical food, functional food, food supplement, or dietary supplement comprising a compound of claim 1 and a physiologically or nutritionally acceptable carrier, adjuvant, excipient, buffer, or diluent.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 15, 2019
From: BIOELECTRON TECHNOLOGY CORPORATION
To: PTC THERAPEUTICS, INC.
Reel/Frame 051041/0478 →
CHANGE OF NAME Recorded Feb 8, 2017
From: EDISON PHARMACEUTICALS, INC.
To: BIOELECTRON TECHNOLOGY CORPORATION
Reel/Frame 041660/0644 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 24, 2015
From: MILLER, GUY M.; KHEIFETS, VIKTORIA
To: EDISON PHARMACEUTICALS, INC.
Reel/Frame 035021/0246 →